Literature DB >> 2574611

Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance data.

L G Schmidt1, R Grohmann, B Müller-Oerlinghausen, M Otto, E Rüther, B Wolf.   

Abstract

Frequencies of abuse and dependence assessed continuously within a drug surveillance system were analysed as a contribution to risk-benefit evaluations of benzodiazepines (BZDs). In 4.7% of 15,296 patients admitted to psychiatric hospitals between 1980 and 1985, BZDs had been involved in some kind of abuse or dependence. Primary BZD dependence, defined as physical dependence on BZDs in patients who had not been dependent before, was observed in about 1% of admitted patients. Linking these data with psychiatric diagnoses revealed a high risk of primary BZD dependence for in-patients (11.8%) with anxiety neurosis (ICD-9, 300.0), and a lower risk for neurotic (300.4) and for endogenous depressives (296.1) (risk 3.7% and 2.7% respectively). Older age was also related to primary BZD dependence. For depressive in-patients, the risk was twice as high in females as in males. Anecdotal observations advocate more systematic investigation of the emotional effects of long-term therapy with BZDs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574611     DOI: 10.1192/bjp.154.6.839

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

1.  Benzodiazepine use among adults residing in the urban settlements of Karachi, Pakistan: a cross sectional study.

Authors:  Saleem P Iqbal; Syed Ahmer; Salima Farooq; Yasmin Parpio; Ambreen Tharani; Rashid A M Khan; Mohammad Zaman
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-01

2.  Predictors of controlled prescription drug non-medical and lifetime use among patients accessing public mental health services in Uganda: a cross-sectional study.

Authors:  Pakoyo Fadhiru Kamba; John Mulangwa; Peter Kageni; Sulah Balikuna; Allan Kengo; Brian Byamah Mutamba; Nelson Sewankambo; Richard Odoi Adome; Pauline Byakika-Kibwika
Journal:  BMJ Open       Date:  2021-03-26       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.